Targeted Metallo-Drugs

Focuses on recent trends and advances in relation to targeted metallodrugs as anti-cancer, anti-microbial and anti-viral agents Addresses resistance issues that are plaguing many chemotherapeutic regimes Endorses and stimulates research in the vibrant field of biological inorganic chemistryShowcases how a ‘multi-targeted’ approach to drug design has led to new families of metallodrugs which may reduce systemic toxicities associated with modern day chemotherapeutics Heralds a new era in drug design and discovery in which we are witnessing a shift from a single- toward a multi-targeted approach